Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Antibodies
Antibody-drug-conjugate
Indications:
Neoplasms / cancer / oncology
Skin and subcutaneous tissue / dermatology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Products
In development: 27
Description:
DualityBio is a leading developer of next generation ADC in oncology and autoimmune diseases. Building on an in-house developed ADC platform, DualityBio has generated a rich pipeline including more than 10 potentially Best-in-Class or First-in-Class ADCs, two of which are in the clinic.
Strong preclinical data and early phase 1 data have validated DualityBio's platform. Besides oncology, DualityBio is also developing ADCs to treat autoimmune diseases such as RA, IBD and SLE. The company's...
